These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30580467)

  • 1. Ibutilide for the control of refractory ventricular tachycardia and ventricular fibrillation in patients with myocardial ischemia and hemodynamic instability.
    Sendra-Ferrer M; Gonzalez MD
    J Cardiovasc Electrophysiol; 2019 Apr; 30(4):503-510. PubMed ID: 30580467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ibutilide Reduces Ventricular Defibrillation Threshold and Organizes Ventricular Fibrillation Activation in Canine Heart Failure Model.
    Zhang N; Luo Q; Jin Q; Han Y; Huang S; Wei Y; Lin C; Chen K; Shen W; Wu L
    Cardiovasc Drugs Ther; 2020 Jun; 34(3):323-334. PubMed ID: 32297025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arrhythmias in the intensive care patient.
    Trappe HJ; Brandts B; Weismueller P
    Curr Opin Crit Care; 2003 Oct; 9(5):345-55. PubMed ID: 14508146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiarrhythmic Drugs for Nonshockable-Turned-Shockable Out-of-Hospital Cardiac Arrest: The ALPS Study (Amiodarone, Lidocaine, or Placebo).
    Kudenchuk PJ; Leroux BG; Daya M; Rea T; Vaillancourt C; Morrison LJ; Callaway CW; Christenson J; Ornato JP; Dunford JV; Wittwer L; Weisfeldt ML; Aufderheide TP; Vilke GM; Idris AH; Stiell IG; Colella MR; Kayea T; Egan D; Desvigne-Nickens P; Gray P; Gray R; Straight R; Dorian P;
    Circulation; 2017 Nov; 136(22):2119-2131. PubMed ID: 28904070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ibutilide in persistent atrial fibrillation refractory to conventional cardioversion methods.
    Naegeli B; Straumann E; Bertel O
    Int J Cardiol; 2005 Mar; 99(2):283-7. PubMed ID: 15749188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment.
    Oral H; Souza JJ; Michaud GF; Knight BP; Goyal R; Strickberger SA; Morady F
    N Engl J Med; 1999 Jun; 340(24):1849-54. PubMed ID: 10369847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catheter Ablation in Patients With Cardiogenic Shock and Refractory Ventricular Tachycardia.
    Ballout JA; Wazni OM; Tarakji KG; Saliba WI; Kanj M; Diab M; Bhargava M; Baranowski B; Dresing TJ; Callahan TD; Cantillon DJ; Rickard J; Martin DO; Varma N; Niebauer MJ; Chung MK; Tchou PJ; Lindsay BD; Hussein AA
    Circ Arrhythm Electrophysiol; 2020 May; 13(5):e007669. PubMed ID: 32281407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of inducible ventricular tachycardia by ibutilide in patients with coronary artery disease. Ibutilide Investigators.
    Wood MA; Stambler BS; Ellenbogen KA; Gilligan DM; Perry KT; Wakefield LK; VanderLugt JT
    Am Heart J; 1998 Jun; 135(6 Pt 1):1048-54. PubMed ID: 9630110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study.
    Ellenbogen KA; Stambler BS; Wood MA; Sager PT; Wesley RC; Meissner MC; Zoble RG; Wakefield LK; Perry KT; Vanderlugt JT
    J Am Coll Cardiol; 1996 Jul; 28(1):130-6. PubMed ID: 8752805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes associated with amiodarone and lidocaine for the treatment of adult in-hospital cardiac arrest with shock-refractory pulseless ventricular tachyarrhythmia.
    Wang CH; Chang WT; Huang CH; Tsai MS; Yu PH; Wu YW; Liu YB; Chen WJ
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 2):327-334. PubMed ID: 31255419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facilitating internal cardioversion of chronic atrial fibrillation with ibutilide--predictors of atrial defibrillation-threshold decrease.
    Efremidis M; Sideris A; Batra R; Manolatos D; Xidonas S; Kardara D; Ekonomou D; Evagelou D; Filippatos G; Kardaras F
    Med Sci Monit; 2004 Jun; 10(6):CR258-63. PubMed ID: 15173670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ibutilide decreases defibrillation threshold by the reduction of activation pattern complexity during ventricular fibrillation in canine hearts.
    Jin Q; Zhou J; Zhang N; Lin CJ; Pang Y; Gu G; Shen WF; Wu LQ
    Chin Med J (Engl); 2012 Aug; 125(15):2701-7. PubMed ID: 22931978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of Nifekalant hydrochloride for life-threatening ventricular tachyarrhythmias in patients with resistance to lidocaine: a study of patients with out-of-hospital cardiac arrest].
    Amino M; Yoshioka K; Iwata O; Fujikura H; Deguchi Y; Ban K; Shiina Y; Goto S; Handa S; Tanabe T; Nakagawa Y; Morita S; Iwase H; Yamamoto I; Inokuchi S; Marutani Y
    J Cardiol; 2003 Mar; 41(3):127-34. PubMed ID: 12674997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of nifekalant hydrochloride in the treatment of fatal ventricular arrhythmia in patients with ischemic heart disease.
    Ando J; Kakishita M; Sakai K; Komura Y; Nishiyama K; Iwabuchi M; Yokoi H; Yasumoto H; Nosaka H; Nobuyoshi M
    Int Heart J; 2005 Jul; 46(4):647-56. PubMed ID: 16157956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiarrhythmic actions of amiodarone: a profile of a paradoxical agent.
    Singh BN
    Am J Cardiol; 1996 Aug; 78(4A):41-53. PubMed ID: 8780328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion of recent-onset atrial fibrillation or flutter with ibutilide after amiodarone has failed.
    Hennersdorf MG; Perings SM; Zühlke C; Heidland UE; Perings C; Heintzen MP; Strauer BE
    Intensive Care Med; 2002 Jul; 28(7):925-9. PubMed ID: 12122531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinidine-Responsive Polymorphic Ventricular Tachycardia in Patients With Coronary Heart Disease.
    Viskin S; Chorin E; Viskin D; Hochstadt A; Halkin A; Tovia-Brodie O; Lee JK; Asher E; Laish-Farkash A; Amit G; Havakuk O; Belhassen B; Rosso R
    Circulation; 2019 May; 139(20):2304-2314. PubMed ID: 30696267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ranolazine therapy in drug-refractory ventricular arrhythmias.
    Curnis A; Salghetti F; Cerini M; Vizzardi E; Sciatti E; Vassanelli F; Villa C; Inama L; Raweh A; Giacopelli D; Bontempi L
    J Cardiovasc Med (Hagerstown); 2017 Jul; 18(7):534-538. PubMed ID: 28368882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Baseline Antiarrhythmic Drug on Outcomes With Ablation in Ischemic Ventricular Tachycardia: A VANISH Substudy (Ventricular Tachycardia Ablation Versus Escalated Antiarrhythmic Drug Therapy in Ischemic Heart Disease).
    Parkash R; Nault I; Rivard L; Gula L; Essebag V; Nery P; Tung S; Raymond JM; Sterns L; Doucette S; Wells G; Tang ASL; Stevenson WG; Sapp JL
    Circ Arrhythm Electrophysiol; 2018 Jan; 11(1):e005663. PubMed ID: 29305400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.